Shah Sujal

CIK 00015888612 companiesHAYWARD, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001588861

Recent Transactions

50 trades

Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (right to buy)
2025-04-17+12,000→ 12,000 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (right to buy)
2025-04-15+8,047→ 8,047 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (right to buy)
2025-04-15+10,394→ 10,394 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−50,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−284,712→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−90,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−536,032→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−649,999→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−357,500→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−800,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−621,101→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−146,875→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−314,120→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Common Stock
2024-03-22−96,250→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−39,375→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Common Stock
2024-03-22−310,420→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−88,351→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−47,916→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-13−1→ 35,799 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2024-03-13$10.00/sh+11,649→ 279,200 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-13−2,288→ 12,845 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-13−22,076→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-13−52,084→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-13−14,372→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-13−18,899→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2024-03-13$9.21/sh+18,899→ 364,808 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2024-03-13$8.43/sh+14,372→ 382,305 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2024-03-13$1.06/sh+14,625→ 293,825 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2024-03-13$1.72/sh+52,084→ 345,909 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2024-03-13$11.69/sh+3,125→ 367,933 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2024-03-13$4.05/sh+22,076→ 404,381 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2024-03-13$2.94/sh+1→ 406,670 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-13−3,125→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2024-03-13$5.78/sh+2,288→ 406,669 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-13−11,649→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-13−14,625→ 0 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-01-24+357,500→ 357,500 total
Award
CymaBay Therapeutics, Inc.
Common Stock
2024-01-24+96,250→ 267,551 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-12-11$19.99/sh−63,975→ 171,301 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-12-11$20.81/sh−890→ 171,301 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-12-11$5.00/sh+890→ 172,191 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Stock Appreciation Right
2023-12-11−12,973→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-12-11$5.00/sh+63,975→ 235,276 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-12-11−31,036→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-12-11−20,856→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-11-13$5.00/sh+44,008→ 215,309 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-11-13$15.89/sh−44,008→ 171,301 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-11-13$5.00/sh+20,855→ 192,156 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-11-13$15.89/sh−20,855→ 171,301 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-11-13−31,036→ 31,036 total

Companies

Recent Filings

Address

C/O CYMABAY THERAPEUTICS, INC. 3876 BAY CENTER PLACE

HAYWARD, CA, 94545

View on SEC.gov